Pricing

Log inSign up

TOLREMO therapeutics

10 people · 0 jobs
‌

TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.

Industries

Biotechnology, Pharmaceutical

Headquarters

Zürich, Switzerland

Employees

1-10

Links

Org chart

Stefanie Flückiger-Mangual
CEO
Collapse
Claudia Escher
COO
JC
Jessica Corson
Chief Business Officer
Florian Vogl
Chief Medical Officer

Board & advisors

Julie M Cherrington
Chair
Erich Greiner
Board Member
Michael Wacker
Board Member

Teams

This company has no teams yet

Offices

Similar companies

Roche

365 followers

Lonza

71 followers

Astellas Pharma

42 followers

AbbVie

278 followers

FUJIFILM Diosynth Biotechnologies

20 followers

Amgen

285 followers

Elanco

28 followers

Pierre Fabre

17 followers

Kedrion Biopharma

19 followers

AstraZeneca

425 followers

Bayer

342 followers

Explore companies